Pfizer Inc. undefined said Wednesday that its experimental respiratory syncytial virus vaccine received Priority Review from the Food and Drug...
Pfizer Inc. said Wednesday that its experimental respiratory syncytial virus vaccine received Priority Review from the Food and Drug Administration. The drug maker is seeking FDA approval of the vaccine in adults who are 60 years old and older. The regulator is now expected to make its decision whether to approve RSVpreF by some time in May of next year. Pfizer's stock has declined 15.8% this year, while the broader S&P 500 is down 17.1%.
... Pfizer Inc. PFE said Wednesday that its experimental respiratory syncytial virus vaccine received Priority Review from the Food and Drug Administration. The drug maker is seeking FDA approval of the vaccine in adults who are 60 years old and older. The regulator is now expected to make its decision whether to approve RSVpreF by some time in May of next year. Pfizer's stock has declined 15.8% this year, while the broader S&P 500 SPX is down 17.1%.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer/BioNTech seek FDA authorization of updated Covid-19 vaccine for children under 5 | CNNPfizer and BioNTech have submitted an application to the US Food and Drug Administration for their updated Covid-19 vaccine to be used as the third shot in the three-dose primary vaccine series for children ages 6 months through 4 years.
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 — not as a booster but part of their initial shots. Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine — each a tenth of the amount adults receive — as their primary series.
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer and its partner BioNTech said Monday that may help prevent severe illness and hospitalization from COVID-19 in little kids, at a time when children’s hospitals already are packed with youngsters hit by other respiratory illnesses.
Read more »
Pfizer asks FDA to clear updated COVID shot for kids under 5Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5.
Read more »
Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young childrenPfizer Inc. undefined and BioNTech SE undefined said Monday that they asked the Food and Drug Administration to authorize their updated COVID-19 vaccine as...
Read more »
Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years.
Read more »